Multiple Drug Resistance Patterns in Various Phylogenetic Groups of Hospital-Acquired Uropathogenic E. coli Isolated from Cancer Patients

Antibiotics
Ahmed Talaat MahmoudHamada Mohamed Halby

Abstract

Cancer patients are more susceptible to several bacterial infections, particularly urinary tract infections caused by uropathogenic E. coli (UPEC). The objective of this work was detection and the phylogenetic characterization of hospital-acquired isolates of uropathogenic E. coli in cancer patients and the determination of its relation with antibiotic resistance. A total of 110 uropathogenic E. coli responsible for hospital-acquired urinary tract infections in cancer patients were included in this study. A triplex PCR was employed to segregate different isolates into four different phylogenetic groups (A, B1, B2 and D). Drug resistance was evaluated by the disc diffusion method. All of the isolates were multiple drug-resistant (MDR) and 38.18% of all UPEC isolates were extended-spectrum beta-lactamase (ESBL) producers from which 52% were positive for the blaCTX-M gene, 40% for the blaTEM gene, and 17% for the blaSHVgene. Among 42 ESBL-producing uropathogenic E. coli isolates, the majority belonged to phylogenetic group B2 (43%), followed by group D (36%), group A (19%) and group B1 (2%). Our results have shown the emergence of MDR isolates among uropathogenic E. coli with the dominance of phylogenetic group B2. Groups A and B1...Continue Reading

References

Oct 27, 1993·JAMA : the Journal of the American Medical Association·J W BachmanM G Timmerman
Jun 1, 1996·American Journal of Infection Control·D PrandoniH Fitzpatrick
Mar 1, 1997·Infectious Disease Clinics of North America·L K Millar, S M Cox
Sep 30, 2000·Applied and Environmental Microbiology·O ClermontE Bingen
Nov 19, 2002·Antimicrobial Agents and Chemotherapy·Antonio OliverFred C Tenover
Nov 27, 2002·Cancer Investigation·Ray Hachem, Issam Raad
May 23, 2006·International Journal of Antimicrobial Agents·Mohamed Hamed Mohamed Al-AgamyIrith Wiegand
Jul 13, 2006·International Journal of Urology : Official Journal of the Japanese Urological Association·Sojun KanamaruShingo Yamamoto
Feb 21, 2009·Journal of Translational Medicine·Hossam M Ashour, Amany El-Sharif
Jul 15, 2009·The Journal of Hospital Infection·M E Falagas, D E Karageorgopoulos
May 9, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kerri A ThomMary-Claire Roghmann
Oct 1, 2011·Brazilian Journal of Microbiology : [publication of the Brazilian Society for Microbiology]·Saira BashirAbdul Haque
Jul 6, 2014·The Journal of Antibiotics·Yanchun WangPing He
Jan 7, 2015·Saudi Journal of Biological Sciences·Sibhghatulla ShaikhMohammad Amjad Kamal
Sep 19, 2015·Journal of Visualized Experiments : JoVE·Laura M KoethSandra McCurdy
May 3, 2016·Journal of Clinical and Diagnostic Research : JCDR·Xavier Alexander Marialouis, Amutha Santhanam
Jun 10, 2016·Journal of Clinical Microbiology·N Esther Babady
Jul 2, 2016·Journal of Infection in Developing Countries·Sareaa Al-Mayahie, Jaafar Jh Al Kuriashy
May 30, 2017·The Open Microbiology Journal·Pooja ShakyaRabin Paudyal
Jan 7, 2018·American Journal of Obstetrics and Gynecology·Christine M Chu, Jerry L Lowder
Jan 18, 2019·The Canadian Journal of Infectious Diseases & Medical Microbiology = Journal Canadien Des Maladies Infectieuses Et De La Microbiologie Médicale·Mengistu AbaynehAlemseged Abdissa

❮ Previous
Next ❯

Methods Mentioned

BETA
PCR
electrophoresis
genotyping

Software Mentioned

Statistics Package for Social Sciences ( SPSS )

Related Concepts

Related Feeds

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.